Clinical Trials Browser

Phase EARLY_PHASE1 × atezolizumab × Gastrointestinal × Clear all

NCT04857684 2025-10-01

SBRT + Atezolizumab + Bevacizumab in Resectable HCC

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma